[Video courtesy of Project Inform]
Jonathan recently broke up from a long-term monogamous relationship. He's been a little depressed but he's also chatting online and dating quite a bit. Condoms aren't always used.
Listen to Jonathan talk about how PrEP has helped ease his mind as he's working through this new stage in his life. And hear from other advocates/experts about the use of PrEP.
Project Inform is a great resource for info on PrEP. Click here.
Sabtu, 12 September 2015
Kamis, 10 September 2015
[VIDEO] Voices of Choice - Lucio from Rio de Janeiro Discusses Being in the iPrEx Open Label PrEP Trial
In the video below, Lucio from Rio discusses his participation in the iPrEx Open Label Study and taking Truvada as a way to prevent HIV infection.
The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.
In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.
The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.
In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.
RESEARCH OPPORTUNITY FOR YOUNG GAY MEN IN THE U.S.
Are you a young gay man living in the United States between the ages of 15 and 17? Are you interested in new methods of preventing HIV, like PrEP?
Project PrEPare is an innovative HIV prevention study designed to explore the safety, acceptability and feasibility of PrEP among young gay men and other men who have sex with men who are at risk for HIV infection in the United States.
The study is taking place at clinical sites across the U.S. in Los Angeles, Philadelphia, Chicago, New Orleans, Boston and Denver. Click here to quickly check if you are eligible to participate.
More information about the study and city-specific contact information can be found on the Project PrEPare website.
Rabu, 09 September 2015
Recruiting Young Gay Men in 6 U.S. Cities for Important PrEP Study
Condoms are not the only way you can have safer sex! Are you a young gay man between the ages of 15 and 17? Interested in new methods of preventing HIV, like PrEP?
Project PrEPare is an innovative HIV prevention study designed to explore the safety, acceptability and feasibility of PrEP among young gay men and other men who have sex with men who are at risk for HIV infection in the United States.
The study is taking place at clinical sites across the U.S. in Los Angeles, Philadelphia, Chicago, New Orleans, Boston and Denver. Click here to quickly check if you are eligible to participate.
“Considering that young men who have sex with men continue to be disproportionately affected by the HIV epidemic in the United States, we are excited to gather youth-specific data on PrEP - the newest addition to the ‘toolbox’ of HIV prevention interventions,” said Dr Sybil. Hosek.
More information about the study and city-specific contact information can be found on the Project PrEPare website.
Senin, 07 September 2015
Bill's "Pretty Epic" PrEP Experience
So, I heard about this PrEP thing on a few websites, did some research, and thought 'Damn, gurl, this is right for me.'
All kidding aside, I am very troubled by this long and cumbersome multi-step process. It should not be this hard to get PrEP. I am a 43 year-old professional and have the fortitude to push through the red tape.But I can assure you I would not done all of this when I was in my late teens or early twenties.
Hello. I've been on PrEP now for 2 months and thought I would share with folks what I had to go through to get my prescription from Kaiser here in Portlandia (Oregon). It was pretty epic.
So, I heard about this PrEP thing on a few websites, did some research, and thought “Damn, gurl, this is right for me.” I went to my primary care doctor which, as fellow Kaiser members know, is S.O.P. for getting anything at Kaiser including a band aid. I don’t know my primary care doc too well (because I am generally healthy and don’t go to the doctor very often), but he seems like a pretty cool guy.
He listened and basically agreed that the medicine was right for me. But when he went to the Kaiser Computer System (aka “Hal”), he was not allowed to prescribe it to me, despite his best efforts. He said Kaiser protocols required that he refer me to an Infectious Disease doctor even though I had no infectious disease. (As an aside, I am somewhat baffled that my primary doc cannot prescribe Truvada, but he is allowed to prescribe powerful opiates and other really fun controlled substances).
Anyway, my primary doc referred me to the Kaiser IDI clinic and that’s when the real fun began. After setting my appointment with an IDI doc (which was 2 weeks out), I received a call from the IDI doc’s assistant telling me I needed to fill out a questionnaire before meeting with the IDI doc. Fine, I said, e-mail it to me.
The questionnaire required me to reveal lots of details about my fairly active sex life. How many times have I had sex in the last year? In the last 2 months? Do I sleep with dudes, ladies, or both? How often do I use condoms when I have sex? Do I do drugs? What do I think of the crisis in the Ukraine? I dutifully completed the questionnaire and sent it off to the IDI people for their consideration and entertainment.
Having jumped through the questionnaire hoop, the next step in My PrEP saga was to meet with the IDI doc. I guess the questionnaire wasn’t enough, so she asked me some more questions. Am I in a relationship? Do I want to be? Do I just meet guys for sex? Where do I meet guys (online, bars, etc.)? Have I ever had any STD? If so, what was it? When was I last tested for HIV? Am I a top or bottom?
If you want to know the answer to the last question send me a private message or find me on Scruff.
The IDI doc told me that I would have to be tested for HIV, gonorrhea, syphilis, hepatitis, and boy cooties. That all made sense. She also said they would test me for something called the CCR5 deletion gene which is that gene mutation that a small percentage of people have that makes them essentially immune from HIV, even if they are really, really, really slutty. I suspect their reasoning is that there would be no reason for me to be on Truvada (which, as the IDI doc pointed out to me several times, is very expensive) if I have some sort of natural HIV immunity. (Turns out I have one copy of the CCR5 gene which means I have “heightened protection against HIV,” but not immunity. That requires two copies of the gene).
Now, after all this, I honestly thought I was going to leave my appointment with the IDI doc with a prescription for PrEP (pending the results of my blood work). Boy, was I wrong.
IDI doc told me that Kaiser policy is to take requests for PrEP to a Committee of IDI docs for a vote. This Committee (which, I have confirmed, is not the same as the Obamacare Death Panels) meets once each month. Their next meeting was two weeks away. My IDI doc said she would advocate that I be on PrEP. I love her.
Interestingly, she also told me that I was only the third person in the entire Kaiser System in Oregon (which is actually pretty large) who had requested PrEP. She also said the other two had been turned down, including a fellow who was in a serodiscordant relationship with an HIV+ partner. After I looked up “serodiscordant” on my iPhone dictionary, I was quite shocked at this. I mean, of all the people who want PrEP, shouldn’t the HIV neg guy who is regularly having sex with a POZ guy be close to the top of the list? But I guess it’s none of my business.
My blood test results came back. HIV neg and no STDs. Yippee! Also, I was informed that the Committee approved my request for PrEP. So the stage was set and I picked up my one-month supply at the Kaiser IDI pharmacy, not that regular Kaiser pharmacy (that would be too easy). When it came time to refill my prescription, I had to have a another appointment with the IDI doc (by phone). Among other things, she asked if I had had any “risky” encounters which I understood to mean condom-less sex. Part of me wanted to say no, because I am on PrEP which makes them not “risky.” But I refrained and gave her the lascivious details she wanted. I then went through another round of blood tests and was approved for a three-month supply.
All kidding aside, I am very troubled by this long and cumbersome multi-step process. It should not be this hard to get PrEP. I am a 43 year-old professional and have the fortitude to push through the red tape. But I can assure you I would not done all of this when I was in my late teens or early twenties. I suspect that is still true of many young men and women today. That is unfortunate because these are the people who need access to this drug the most. As we all have heard, HIV infection rates are increasing among gay men who are 16-25 years-old.
I hope Kaiser changes its process for prescribing PrEP. I understand the need for the preliminary and routine blood work and on-going counseling about the extreme importance of taking it daily. But there is no reason that can’t be done by primary care physicians who often are the ones that know a patient best.
Sabtu, 05 September 2015
The New Revolution: Bob Grant Talks PrEP in Special Issue of Positively Aware
by Robert Grant, MD, MPH (via Positively Aware's recent "Let's Talk about PrEP" issue)
Antiretroviral therapy has revolutionized care for people living with HIV/AIDS by prolonging life and restoring health, preventing transmission to uninfected partners, and preventing tuberculosis disease. These same medications can be taken by HIV-negative people with the goal of staying free of HIV. The combination of highly active antiretroviral interventions for both HIV prevention and treatment has led to unprecedented optimism about the prospect of ending AIDS.
The preventive use of anti-HIV medicines by HIV-negative people is called post-exposure prophylaxis (or PEP) if the medicines are started after sex or a needle stick that could lead to HIV transmission. Pre-exposure prophylaxis, or PrEP, is when medicines are used before and after possible exposures to HIV infection.
Read the rest here.
"PrEP is a proven concept. A single tablet that contains two medications originally approved to treat HIV/AIDS, tenofovir and emtricitabine (brand name “Truvada” in the United States), was approved to prevent sexual transmission of HIV by the Food and Drug Administration (FDA) in July 2012. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have issued guidelines for the use of PrEP. The medication is already available in generic form to people living in the poorest countries of the world."
Antiretroviral therapy has revolutionized care for people living with HIV/AIDS by prolonging life and restoring health, preventing transmission to uninfected partners, and preventing tuberculosis disease. These same medications can be taken by HIV-negative people with the goal of staying free of HIV. The combination of highly active antiretroviral interventions for both HIV prevention and treatment has led to unprecedented optimism about the prospect of ending AIDS.
The preventive use of anti-HIV medicines by HIV-negative people is called post-exposure prophylaxis (or PEP) if the medicines are started after sex or a needle stick that could lead to HIV transmission. Pre-exposure prophylaxis, or PrEP, is when medicines are used before and after possible exposures to HIV infection.
Read the rest here.
Jumat, 04 September 2015
[VIDEO] Voices of Choice - Garland from Chicago Talks About Being in the iPrEx Open Label PrEP Trial
In the video below, Garland from Chicago discusses his participation in the iPrEx Open Label Study and taking Truvada as a way to prevent HIV infection. The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.
In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.
Thanks to the iPrEx team, My PrEP Experience will be sharing a number of videos from iPrEx study participants over the coming days and weeks. Check back often, or like our partner Project RSP! on FB and follow along with all the new videos that way.
If YOU are taking Truvada as PrEP, we'd love to hear your story. You can share your experience in a video, or you can write something up. Whatever you want to do - we want to hear your experience - whether taking Truvada as PrEP was a good experience or a bad experience - or anywhere in between. Email myprepexperience@gmail.com and let us know!
In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.
Thanks to the iPrEx team, My PrEP Experience will be sharing a number of videos from iPrEx study participants over the coming days and weeks. Check back often, or like our partner Project RSP! on FB and follow along with all the new videos that way.
If YOU are taking Truvada as PrEP, we'd love to hear your story. You can share your experience in a video, or you can write something up. Whatever you want to do - we want to hear your experience - whether taking Truvada as PrEP was a good experience or a bad experience - or anywhere in between. Email myprepexperience@gmail.com and let us know!
Selasa, 25 Agustus 2015
PrEPed in Japan
I have had no side effects at all, except feelings of reassurance and security!
I am just angry and frustrated that I didn't know about PrEP earlier and that it is not being promoted in countries like Japan or my home country (which promotes condoms only). I am angry because I believe I could have convinced my boyfriend to go on it and could have protected him from infection via PrEP.
by Anonymous in Tokyo
I recently self-initiated PrEP in Japan (using Truvada generic Tenvir-EM by Cipla), and I wanted to share my experience for anyone outside the U.S. who may face similar issues.
My Japanese boyfriend contracted HIV earlier this year. We found out after I contracted an STD from him and he tested positive for HIV (while I remained negative). We have been told by health workers that HIV infection rates are increasing significantly in Tokyo (anecdotally among young Japanese who like foreigners/tourists).
I found out about PrEP in the U.S. online but we were told by my boyfriend's doctor that Truvada is not covered for PrEP by Japan's health insurance system. I couldn't afford to pay for Truvada in full, so I decided to buy the Truvada generic Tenvir-EM for about $100 per month via a Japanese online pharmacy (manufactured by Cipla in India).
After several blood tests and my annual health check including kidneys (I will increase the kidney function check to four times a year going forward), I now self test for HIV monthly using the OraQuick oral-swab antibody 20-minute tests, which I buy from Amazon (about four at a time at a cost of $50 each). So the tests and pills cost me $150 per month in total (including shipping) but I think it is worth it.
I have had no side effects at all, except feelings of reassurance and security!
I am just angry and frustrated that I didn't know about PrEP earlier and that it is not being promoted in countries like Japan or my home country (which promotes condoms only). I am angry because I believe I could have convinced my boyfriend to go on it and could have protected him from infection via PrEP.
He is not on any HIV medication yet so we still use condoms when he tops me, but now that I am on PrEP I am more relaxed about things when I top him. The fear has gone and our relationship is stronger than ever, thanks to one small pill a day.
I believe every government and HIV organizations have a moral responsibility to make it as easy and cheap as possible for every gay man on the planet to be on PrEP and stop all new infections in the community. If it works 100 percent of the time for us who take it daily, it should be promoted as the first line of defense against HIV (together with condoms against other STDs).
I aim to let as many people know about PrEP as possible.
Langganan:
Postingan (Atom)





